Identification of antigens presented by MHC for vaccines against tuberculosis

Mycobacterium tuberculosis (M.tb) is responsible for more deaths globally than any other pathogen. The only available vaccine, bacillus Calmette-Guérin (BCG), has variable efficacy throughout the world. A more effective vaccine is urgently needed. The immune response against tuberculosis relies, at...

Full description

Bibliographic Details
Main Authors: Bettencourt, P, Müller, J, Nicastri, A, Cantillon, D, Madhavan, M, Charles, PD, Fotso, CB, Wittenberg, R, Bull, N, Pinpathomrat, N, Waddell, SJ, Stylianou, E, Hill, AVS, Ternette, N, McShane, H
Format: Journal article
Language:English
Published: Springer Nature 2020
_version_ 1797059980515344384
author Bettencourt, P
Müller, J
Nicastri, A
Cantillon, D
Madhavan, M
Charles, PD
Fotso, CB
Wittenberg, R
Bull, N
Pinpathomrat, N
Waddell, SJ
Stylianou, E
Hill, AVS
Ternette, N
McShane, H
author_facet Bettencourt, P
Müller, J
Nicastri, A
Cantillon, D
Madhavan, M
Charles, PD
Fotso, CB
Wittenberg, R
Bull, N
Pinpathomrat, N
Waddell, SJ
Stylianou, E
Hill, AVS
Ternette, N
McShane, H
author_sort Bettencourt, P
collection OXFORD
description Mycobacterium tuberculosis (M.tb) is responsible for more deaths globally than any other pathogen. The only available vaccine, bacillus Calmette-Guérin (BCG), has variable efficacy throughout the world. A more effective vaccine is urgently needed. The immune response against tuberculosis relies, at least in part, on CD4+ T cells. Protective vaccines require the induction of antigen-specific CD4+ T cells via mycobacterial peptides presented by MHC class-II in infected macrophages. In order to identify mycobacterial antigens bound to MHC, we have immunoprecipitated MHC class-I and class-II complexes from THP-1 macrophages infected with BCG, purified MHC class-I and MHC class-II peptides and analysed them by liquid chromatography tandem mass spectrometry. We have successfully identified 94 mycobacterial peptides presented by MHC-II and 43 presented by MHC-I, from 76 and 41 antigens, respectively. These antigens were found to be highly expressed in infected macrophages. Gene ontology analysis suggests most of these antigens are associated with membranes and involved in lipid biosynthesis and transport. The sequences of selected peptides were confirmed by spectral match validation and immunogenicity evaluated by IFN-gamma ELISpot against peripheral blood mononuclear cell from volunteers vaccinated with BCG, M.tb latently infected subjects or patients with tuberculosis disease. Three antigens were expressed in viral vectors, and evaluated as vaccine candidates alone or in combination in a murine aerosol M.tb challenge model. When delivered in combination, the three candidate vaccines conferred significant protection in the lungs and spleen compared with BCG alone, demonstrating proof-of-concept for this unbiased approach to identifying new candidate antigens.
first_indexed 2024-03-06T20:11:18Z
format Journal article
id oxford-uuid:2aa4f0a0-b014-4859-bd3a-9aa99e19047e
institution University of Oxford
language English
last_indexed 2024-03-06T20:11:18Z
publishDate 2020
publisher Springer Nature
record_format dspace
spelling oxford-uuid:2aa4f0a0-b014-4859-bd3a-9aa99e19047e2022-03-26T12:26:20ZIdentification of antigens presented by MHC for vaccines against tuberculosisJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:2aa4f0a0-b014-4859-bd3a-9aa99e19047eEnglishSymplectic ElementsSpringer Nature2020Bettencourt, PMüller, JNicastri, ACantillon, DMadhavan, MCharles, PDFotso, CBWittenberg, RBull, NPinpathomrat, NWaddell, SJStylianou, EHill, AVSTernette, NMcShane, HMycobacterium tuberculosis (M.tb) is responsible for more deaths globally than any other pathogen. The only available vaccine, bacillus Calmette-Guérin (BCG), has variable efficacy throughout the world. A more effective vaccine is urgently needed. The immune response against tuberculosis relies, at least in part, on CD4+ T cells. Protective vaccines require the induction of antigen-specific CD4+ T cells via mycobacterial peptides presented by MHC class-II in infected macrophages. In order to identify mycobacterial antigens bound to MHC, we have immunoprecipitated MHC class-I and class-II complexes from THP-1 macrophages infected with BCG, purified MHC class-I and MHC class-II peptides and analysed them by liquid chromatography tandem mass spectrometry. We have successfully identified 94 mycobacterial peptides presented by MHC-II and 43 presented by MHC-I, from 76 and 41 antigens, respectively. These antigens were found to be highly expressed in infected macrophages. Gene ontology analysis suggests most of these antigens are associated with membranes and involved in lipid biosynthesis and transport. The sequences of selected peptides were confirmed by spectral match validation and immunogenicity evaluated by IFN-gamma ELISpot against peripheral blood mononuclear cell from volunteers vaccinated with BCG, M.tb latently infected subjects or patients with tuberculosis disease. Three antigens were expressed in viral vectors, and evaluated as vaccine candidates alone or in combination in a murine aerosol M.tb challenge model. When delivered in combination, the three candidate vaccines conferred significant protection in the lungs and spleen compared with BCG alone, demonstrating proof-of-concept for this unbiased approach to identifying new candidate antigens.
spellingShingle Bettencourt, P
Müller, J
Nicastri, A
Cantillon, D
Madhavan, M
Charles, PD
Fotso, CB
Wittenberg, R
Bull, N
Pinpathomrat, N
Waddell, SJ
Stylianou, E
Hill, AVS
Ternette, N
McShane, H
Identification of antigens presented by MHC for vaccines against tuberculosis
title Identification of antigens presented by MHC for vaccines against tuberculosis
title_full Identification of antigens presented by MHC for vaccines against tuberculosis
title_fullStr Identification of antigens presented by MHC for vaccines against tuberculosis
title_full_unstemmed Identification of antigens presented by MHC for vaccines against tuberculosis
title_short Identification of antigens presented by MHC for vaccines against tuberculosis
title_sort identification of antigens presented by mhc for vaccines against tuberculosis
work_keys_str_mv AT bettencourtp identificationofantigenspresentedbymhcforvaccinesagainsttuberculosis
AT mullerj identificationofantigenspresentedbymhcforvaccinesagainsttuberculosis
AT nicastria identificationofantigenspresentedbymhcforvaccinesagainsttuberculosis
AT cantillond identificationofantigenspresentedbymhcforvaccinesagainsttuberculosis
AT madhavanm identificationofantigenspresentedbymhcforvaccinesagainsttuberculosis
AT charlespd identificationofantigenspresentedbymhcforvaccinesagainsttuberculosis
AT fotsocb identificationofantigenspresentedbymhcforvaccinesagainsttuberculosis
AT wittenbergr identificationofantigenspresentedbymhcforvaccinesagainsttuberculosis
AT bulln identificationofantigenspresentedbymhcforvaccinesagainsttuberculosis
AT pinpathomratn identificationofantigenspresentedbymhcforvaccinesagainsttuberculosis
AT waddellsj identificationofantigenspresentedbymhcforvaccinesagainsttuberculosis
AT stylianoue identificationofantigenspresentedbymhcforvaccinesagainsttuberculosis
AT hillavs identificationofantigenspresentedbymhcforvaccinesagainsttuberculosis
AT ternetten identificationofantigenspresentedbymhcforvaccinesagainsttuberculosis
AT mcshaneh identificationofantigenspresentedbymhcforvaccinesagainsttuberculosis